Journal of Acute Disease

REVIEW ARTICLE
Year
: 2021  |  Volume : 10  |  Issue : 6  |  Page : 221--226

Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review


Jugal Sutradhar1, Bapi Ray Sarkar2 
1 Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002, India
2 Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Darjeeling, West Bengal 734013, India

Correspondence Address:
Jugal Sutradhar
Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002
India

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has become a pandemic disease. It also increases the risk of co-infections. Mucormycosis is a severe fungal infectious disease and its causative agent, mucormycetes, belongs to an opportunist fungus Mucoraceae family. Mucormycosis in COVID-19 patients with mucormycosis presents an additional challenge worldwide. Mucormycosis shares certain risk factors and signs and symptoms with COVID-19. In this review, we summarize manifestations and risk factors of mucormycosis and COVID-19.


How to cite this article:
Sutradhar J, Sarkar BR. Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review.J Acute Dis 2021;10:221-226


How to cite this URL:
Sutradhar J, Sarkar BR. Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review. J Acute Dis [serial online] 2021 [cited 2022 May 22 ];10:221-226
Available from: https://www.jadweb.org/article.asp?issn=2221-6189;year=2021;volume=10;issue=6;spage=221;epage=226;aulast=Sutradhar;type=0